NEW YORK, March 12, 2026 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that a retrospective ...
While the accreditation is a large step forward, most trauma patients will still need to be transported to a higher-level facility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results